Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Esophageal Cancer · Surgery · Neoadjuvant Treatment · Survival

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou, Henan, China

    Contact: Study coordinator (Yan Zheng, PhD) · sunnyzheng1@126.com · 86-371-65587226
    Contact: Principal Investigator (Yan Zheng, PhD)
Study leads
  • Yan Zheng, PhD, MD

    Principal Investigator

    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university